Newsbenzinga
Inspire Medical Systems Analysts Raise Their Forecasts Following Strong Q2 Results
· Published
Article summary
INSPI beats expectations, raises FY26 guidance. Analysts raise price targets to $59 & $60. Stock jumps 14.6% in pre-market trading. #INSP
An excerpt from the original article.
Comments —
Loading comments…